European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy
Authors:
Open Access
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Clinical Oncology
- Vol. 30 (7) , 448-454
Abstract
No abstract availableKeywords
Funding Information
- EORTC Cancer Research Fund
- Epizyme, Inc
This publication has 22 references indexed in Scilit:
- Role of Palliative Chemotherapy in Advanced Epithelioid SarcomaAmerican Journal of Clinical Oncology, 2012
- Prognostic determinants in epithelioid sarcomaEuropean Journal of Cancer, 2011
- Prognostic Factors for Survival in Patients with Epithelioid Sarcoma: 441 Cases from the SEER DatabaseClinical Orthopaedics and Related Research, 2009
- Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)Journal of Clinical Oncology, 2009
- Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid SarcomaAmerican Journal of Surgical Pathology, 2009
- Epithelioid SarcomaAmerican Journal of Clinical Pathology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Epithelioid sarcoma: the University of Washington experienceThe American Journal of Surgery, 2008
- Epithelioid sarcoma in children and adolescentsCancer, 2005
- Treatment of Epithelioid Sarcoma at the Royal Marsden HospitalSarcoma, 2003